Chemoptogenetic damage to mitochondria causes rapid telomere dysfunction
Significance
It is highly controversial whether secondary reactive oxygen species generated by dysfunctional mitochondria are able to diffuse across the cytoplasm to the nucleus and cause subsequent nuclear changes. We have developed a targeted chemoptogenetic technology to induce mitochondrial dysfunction by generating short-lived highly reactive singlet oxygen exclusively in the mitochondria, with precise spatiotemporal control by light stimulation. Through careful analysis of the events involving mitochondrial dysfunction and subsequent nuclear oxidative stress that resulted in specific telomere damage, we delineated the mechanism of mitochondria–telomere axis of cellular damage. Our findings revealed a fundamental mechanism underlying the pathophysiological role of mitochondrial singlet oxygen, with important ramifications for understanding the role of mitochondrial signaling in aging and cancer among other human diseases.
Top-30
Journals
|
1
2
3
4
|
|
|
International Journal of Molecular Sciences
4 publications, 2.96%
|
|
|
Redox Biology
4 publications, 2.96%
|
|
|
Nature Communications
3 publications, 2.22%
|
|
|
Angewandte Chemie - International Edition
3 publications, 2.22%
|
|
|
Angewandte Chemie
3 publications, 2.22%
|
|
|
Nucleic Acids Research
3 publications, 2.22%
|
|
|
Journal of Cell Science
2 publications, 1.48%
|
|
|
Frontiers in Immunology
2 publications, 1.48%
|
|
|
Mitochondrion
2 publications, 1.48%
|
|
|
Ageing Research Reviews
2 publications, 1.48%
|
|
|
Cell Metabolism
2 publications, 1.48%
|
|
|
Current Opinion in Genetics and Development
2 publications, 1.48%
|
|
|
Mechanisms of Ageing and Development
2 publications, 1.48%
|
|
|
Aging Cell
2 publications, 1.48%
|
|
|
eLife
2 publications, 1.48%
|
|
|
Cancers
2 publications, 1.48%
|
|
|
Frontiers in Cardiovascular Medicine
2 publications, 1.48%
|
|
|
DNA Repair
2 publications, 1.48%
|
|
|
International Journal of Biological Macromolecules
2 publications, 1.48%
|
|
|
Current Pharmaceutical Design
1 publication, 0.74%
|
|
|
Small
1 publication, 0.74%
|
|
|
Gerontology
1 publication, 0.74%
|
|
|
Lasers in Medical Science
1 publication, 0.74%
|
|
|
Journal of Clinical Medicine
1 publication, 0.74%
|
|
|
Cells
1 publication, 0.74%
|
|
|
Antioxidants
1 publication, 0.74%
|
|
|
Biomedicines
1 publication, 0.74%
|
|
|
Frontiers in Chemistry
1 publication, 0.74%
|
|
|
Frontiers in Cell and Developmental Biology
1 publication, 0.74%
|
|
|
1
2
3
4
|
Publishers
|
5
10
15
20
25
30
35
40
|
|
|
Elsevier
39 publications, 28.89%
|
|
|
Wiley
19 publications, 14.07%
|
|
|
Springer Nature
18 publications, 13.33%
|
|
|
MDPI
12 publications, 8.89%
|
|
|
Cold Spring Harbor Laboratory
10 publications, 7.41%
|
|
|
Oxford University Press
8 publications, 5.93%
|
|
|
Frontiers Media S.A.
6 publications, 4.44%
|
|
|
American Chemical Society (ACS)
3 publications, 2.22%
|
|
|
Taylor & Francis
3 publications, 2.22%
|
|
|
The Company of Biologists
2 publications, 1.48%
|
|
|
eLife Sciences Publications
2 publications, 1.48%
|
|
|
OAE Publishing Inc.
2 publications, 1.48%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.74%
|
|
|
S. Karger AG
1 publication, 0.74%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 0.74%
|
|
|
Acta Naturae Ltd
1 publication, 0.74%
|
|
|
Hindawi Limited
1 publication, 0.74%
|
|
|
American Association for Cancer Research (AACR)
1 publication, 0.74%
|
|
|
American Physiological Society
1 publication, 0.74%
|
|
|
Research Square Platform LLC
1 publication, 0.74%
|
|
|
Impact Journals
1 publication, 0.74%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.74%
|
|
|
5
10
15
20
25
30
35
40
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.